Creative Medical Technology Holdings Inc
CELZ2.885USD
+0.015+0.52%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
7.44MCap. mercado
PérdidaP/E TTM
Más Datos de Creative Medical Technology Holdings Inc Compañía
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Información de la empresa
Símbolo de cotizaciónCELZ
Nombre de la empresaCreative Medical Technology Holdings Inc
Fecha de salida a bolsaMay 01, 2009
Director ejecutivoMr. Timothy Warbington
Número de empleados4
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 01
Dirección211 E. Osborn Rd.
CiudadPHOENIX
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal85012
Teléfono14803992822
Sitio Webhttps://creativemedicaltechnology.com/
Símbolo de cotizaciónCELZ
Fecha de salida a bolsaMay 01, 2009
Director ejecutivoMr. Timothy Warbington
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: jue., 24 de jul
Actualizado: jue., 24 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Armistice Capital LLC
5.72%
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.71%
The Vanguard Group, Inc.
0.68%
HRT Financial LP
0.50%
Other
91.50%
Accionistas
Accionistas
Proporción
Armistice Capital LLC
5.72%
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.71%
The Vanguard Group, Inc.
0.68%
HRT Financial LP
0.50%
Other
91.50%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
5.85%
Investment Advisor/Hedge Fund
1.42%
Corporation
0.88%
Investment Advisor
0.64%
Individual Investor
0.49%
Other
90.73%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
25
239.86K
9.28%
+97.57K
2025Q1
27
239.16K
9.28%
+93.67K
2024Q4
29
67.44K
3.86%
-172.00K
2024Q3
32
114.73K
8.54%
-150.07K
2024Q2
34
115.50K
8.55%
-269.83K
2024Q1
36
151.46K
11.09%
-154.43K
2023Q4
38
64.97K
4.67%
-273.04K
2023Q3
42
127.49K
15.08%
-223.19K
2023Q2
41
127.02K
15.07%
-210.98K
2023Q1
39
140.30K
16.02%
-112.96K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Armistice Capital LLC
148.00K
5.72%
+148.00K
--
Mar 31, 2025
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Geode Capital Management, L.L.C.
18.27K
0.71%
+7.96K
+77.22%
Mar 31, 2025
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Mar 31, 2025
HRT Financial LP
13.05K
0.5%
+13.05K
--
Mar 31, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Tower Research Capital LLC
3.15K
0.12%
+1.50K
+91.26%
Mar 31, 2025
Osaic Holdings, Inc.
1.26K
0.05%
+1.13K
+862.60%
Mar 31, 2025
Northern Trust Investments, Inc.
805.00
0.03%
+805.00
--
Dec 31, 2023
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Fecha
Tipo
Relación
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
